Volta

Oleic Acid Levels in HSALR Mouse Model of Myotonic Dystrophy Type 1

Unknown authors · 2026
hash_id: f4ea02e9e5e0e0736076e25c6efac58587c70bf7df1e8130aef1bedbeeb9f3e4 · DOI: 10.3390/ijms27104211

Myotonic dystrophy type 1 (DM1) is characterized by altered RNA processing, muscle wasting and metabolic dysregulation. In a previous in vitro study, we found reduced endogenous oleic acid (OA; 18:1n-9) in myogenic cells from DM1 patients, and short-term OA supplementation rescued key disease readouts. Here, we asked whether lipid pathways are perturbed in a DM1 in vivo background. We employed the widely used HSALR mouse model, which expresses human skeletal alpha-actin transcripts harbouring expanded CTG repeats and recapitulates key DM1 phenotypes. RNA-seq-derived functional enrichment across three independent HSALR datasets revealed a consistent enrichment of downregulated GO terms related to fatty-acid metabolism, suggesting impaired lipid handling. Guided by transcriptomic evidence of fatty-acid pathway downregulation, we quantified endogenous OA in HSALR mice …

Reference & gravity metrics

Citations
0
Citations / yr
0.00
RCR
Mass
0.00
Depth
0.00
Momentum
0.000
Burn rate
0.00 ATP/day
Start price
25.00 ATP

Secondary-market trade history

No secondary-market trades recorded for this Volta yet.

References (0)

No outbound references recorded.

Cited by (1)

Treatments and therapies for symptoms and clinical manifestations of adult type… secondary